These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3604876)

  • 21. Effect of recainam on the energy required for ventricular defibrillation in dogs as assessed with implanted electrodes.
    Frame LH; Sheldon JH
    J Am Coll Cardiol; 1988 Sep; 12(3):746-52. PubMed ID: 3403835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barium decreases defibrillation energy requirements.
    Dorian P; Witkowski FX; Penkoske PA; Feder-Elituv RS
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):107-12. PubMed ID: 7511721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course of fibrillation and defibrillation thresholds after an intravenous bolus of amiodarone--an experimental study.
    Tsagalou EP; Anastasiou-Nana MI; Charitos CE; Siafakas CX; Drakos SG; Ntalianis A; Terrovitis JV; Mavrikakis EM; Doufas A; Nanas JN
    Resuscitation; 2004 Apr; 61(1):83-9. PubMed ID: 15081186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model.
    Dorian P; Wang M; David I; Feindel C
    Circulation; 1991 Feb; 83(2):614-21. PubMed ID: 1991379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of verapamil and Bay K 8644 on defibrillation energy requirements in dogs.
    Schräder R; Brooks M; Echt DS
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):839-50. PubMed ID: 1376802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of oral amiodarone on left ventricular function in dogs: clinical implications for patients with life-threatening ventricular tachycardia.
    Landymore R; Marble A; MacKinnon G; Leadon R; Gardner M
    Ann Thorac Surg; 1984 Feb; 37(2):141-6. PubMed ID: 6696547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The defibrillation threshold: a comparison of anesthetics and measurement methods.
    Gill RM; Sweeney RJ; Reid PR
    Pacing Clin Electrophysiol; 1993 Apr; 16(4 Pt 1):708-14. PubMed ID: 7683796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic effects of intravenous amiodarone.
    Kosinski EJ; Albin JB; Young E; Lewis SM; LeLand OS
    J Am Coll Cardiol; 1984 Sep; 4(3):565-70. PubMed ID: 6470338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential pulse internal defibrillation: is there an advantage to "switched" current pathways?
    Fain ES; Sweeney MB; Franz MR
    Am Heart J; 1989 Oct; 118(4):717-24. PubMed ID: 2801478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of cardiac defibrillation in open-chest dogs with unipolar DC-coupled simultaneous activation and shock potential recordings.
    Witkowski FX; Penkoske PA; Plonsey R
    Circulation; 1990 Jul; 82(1):244-60. PubMed ID: 2364513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation between amiodarone and desethylamiodarone plasma concentrations and ventricular defibrillation energy requirements.
    Daoud EG; Man KC; Horwood L; Morady F; Strickberger SA
    Am J Cardiol; 1997 Jan; 79(1):97-100. PubMed ID: 9024750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic oral amiodarone but not dronedarone therapy increases ventricular defibrillation threshold during acute myocardial ischemia in a closed-chest animal model.
    Chevalier P; Timour Q; Morel E; Bui-Xuan B
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):523-8. PubMed ID: 22330675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of quinidine and bretylium on defibrillation energy requirements.
    Dorian P; Fain ES; Davy JM; Winkle RA
    Am Heart J; 1986 Jul; 112(1):19-25. PubMed ID: 3728282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of electrophysiologic changes during oral loading of amiodarone and after withdrawal of amiodarone in the unsedated dog.
    Tuna IC; Qi AC; Gornick C; Bolman RM; Benditt DG
    Circulation; 1985 Dec; 72(6):1380-5. PubMed ID: 4064280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of biphasic and monophasic defibrillation waveforms in an isolated rabbit heart preparation.
    Holley LK; McCulloch RM
    Cardiovasc Res; 1991 Dec; 25(12):979-83. PubMed ID: 1806236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol.
    Merot J; Charpentier F; Poirier JM; Coutris G; Weissenburger J
    Cardiovasc Res; 1999 Nov; 44(2):303-14. PubMed ID: 10690307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Selective Late Sodium Current Inhibitor Eleclazine, Unlike Amiodarone, Does Not Alter Defibrillation Threshold or Dominant Frequency of Ventricular Fibrillation.
    Silva AF; Bonatti R; Batatinha JA; Nearing BD; Zeng D; Belardinelli L; Verrier RL
    J Cardiovasc Pharmacol; 2017 Mar; 69(3):178-182. PubMed ID: 28045761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Internal cardioversion of atrial fibrillation in sheep.
    Cooper RA; Alferness CA; Smith WM; Ideker RE
    Circulation; 1993 May; 87(5):1673-86. PubMed ID: 8491023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved internal defibrillation success with shocks timed to the morphology electrogram.
    Hsu W; Lin Y; Lang DJ; Jones JL
    Circulation; 1998 Aug; 98(8):808-12. PubMed ID: 9727552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation.
    Echt DS; Black JN; Barbey JT; Coxe DR; Cato E
    Circulation; 1989 May; 79(5):1106-17. PubMed ID: 2469545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.